Brain47Brain47Join Brain47
1RV

Rhythm Pharmaceuticals Inc

Healthcare · EUR · F

1RV

Price

€74.233

+0.98%

Cap

€6.45B

Earnings

—

30d Trend

+7.5%

1RV
Loading chart data...
0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

0
MODERATE
Risk Level76
Quality53
Momentum57
Technical51
Fundamentals15

Raw weighted: 49×Macro 0.99 (−1%)=49

RISK

76/100
90d Volatility
50.5%High
ATR %
4.7%High daily moves
Max Drawdown (1Y)
-35.5%Volatile

QUALITY

53/100
Piotroski F-Score
4/9Average
Debt/Equity
0.73Moderate
Accruals
-16.8%Cash earnings

MOMENTUM

57/100
12-1M Momentum
+44.8%Strong uptrend
6-1M Momentum
-24.8%Negative
1M Return
+8.6%Strong recent gains
Relative Strength
+1.7% vs sectorIn-line

TECHNICAL

51/100
RSI (14)
53.9Neutral
Price vs SMA200
-7.3%Bearish trend
MACD
-0.09Bearish momentum
Bollinger Band
61%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.143Noisy/choppy

FUNDAMENTALS

15/100
P/S
31.4Expensive

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★50
3-12 months37
1-5+ years39

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Rhythm Pharmaceuticals Inc at 49/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 57/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

DETAILED ANALYSIS

Limited short-term thesis. Momentum (57) and Quality (53) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. I classify this as a speculative position — elevated volatility at 51% and asymmetric payoff potential define the opportunity.

speculativeScore: 49/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.